Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01999179 · ClinicalTrials.gov registry record · NA
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT01999179: Completed NA study, sponsored by Medical College of Wisconsin.
NCT01999179 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01999179, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The goal of the pilot study is to determine if a multicenter prospective cohort study of cancer patients with blood clots associated with catheters is feasible. Cancer patients with catheter-related thrombosis treated with one month of anticoagulation will be evaluated for for post-thrombotic syndrome. Laboratory biomarkers will be evaluated as predictors of recurrent thrombosis.
Primary Outcome
Percentage of participants who completed post-thrombotic syndrome assessments
Interventions
- DRUG Heparin, Low-Molecular-Weight, or direct oral anticoagulants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2014-06 |
| Est. Completion | 2022-04-26 |
| Phase | NA |
What the finished NCT01999179 record still lists
NCT01999179 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Heparin, Low-Molecular-Weight, or direct oral anticoagulants is the first listed.
NCT01999179 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01999179 about?
NCT01999179 is a clinical study titled "Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis". The goal of the pilot study is to determine if a multicenter prospective cohort study of cancer patients with blood clots associated with catheters is feasible. Cancer patients with catheter-related thrombosis treated with one month of anticoagulation will be evaluated for for post-thrombotic syndro...
What is the current status of trial NCT01999179?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2014-06. Estimated completion is 2022-04-26.
What interventions are being tested in trial NCT01999179?
The interventions under investigation include: Heparin, Low-Molecular-Weight, or direct oral anticoagulants (DRUG).
Who is sponsoring clinical trial NCT01999179?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01999179's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia